

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.40664963 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.78595080 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.78595080 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.34916471 |
| 5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.96170022 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.83154409 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.51185131 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 5.35573667 |
| 9 | positive thymic T cell selection (GO:0045059) | 5.19765130 |
| 10 | negative T cell selection (GO:0043383) | 5.09870634 |
| 11 | B cell receptor signaling pathway (GO:0050853) | 4.97162270 |
| 12 | negative thymic T cell selection (GO:0045060) | 4.93298940 |
| 13 | mast cell activation (GO:0045576) | 4.72559498 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.64975136 |
| 15 | negative regulation of cell killing (GO:0031342) | 4.64975136 |
| 16 | regulation of B cell differentiation (GO:0045577) | 4.63855628 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.61123688 |
| 18 | leukocyte aggregation (GO:0070486) | 4.58117971 |
| 19 | positive regulation of B cell differentiation (GO:0045579) | 4.56706086 |
| 20 | positive T cell selection (GO:0043368) | 4.56190017 |
| 21 | T cell migration (GO:0072678) | 4.51027618 |
| 22 | response to interleukin-15 (GO:0070672) | 4.49921184 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 4.47541573 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 4.47541573 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.47541573 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.47541573 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.47541573 |
| 28 | modulation by symbiont of host immune response (GO:0052553) | 4.47541573 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.31877246 |
| 30 | cellular response to interleukin-15 (GO:0071350) | 4.29720847 |
| 31 | detection of other organism (GO:0098543) | 4.28747336 |
| 32 | detection of bacterium (GO:0016045) | 4.27423510 |
| 33 | thymic T cell selection (GO:0045061) | 4.26271102 |
| 34 | T cell selection (GO:0045058) | 4.26136292 |
| 35 | mast cell activation involved in immune response (GO:0002279) | 4.14027490 |
| 36 | mast cell degranulation (GO:0043303) | 4.14027490 |
| 37 | interferon-gamma production (GO:0032609) | 4.13514934 |
| 38 | negative regulation of phagocytosis (GO:0050765) | 4.12990519 |
| 39 | negative regulation of T cell mediated immunity (GO:0002710) | 4.09699640 |
| 40 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.07503982 |
| 41 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.06529373 |
| 42 | cellular extravasation (GO:0045123) | 4.04802125 |
| 43 | ribosomal small subunit assembly (GO:0000028) | 4.03650068 |
| 44 | neutrophil activation involved in immune response (GO:0002283) | 4.01881159 |
| 45 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.97690664 |
| 46 | T cell homeostasis (GO:0043029) | 3.89490136 |
| 47 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.86248205 |
| 48 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.84811159 |
| 49 | T cell receptor signaling pathway (GO:0050852) | 3.81270929 |
| 50 | macrophage activation involved in immune response (GO:0002281) | 3.79248403 |
| 51 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.69839182 |
| 52 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.63819418 |
| 53 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.61412711 |
| 54 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.57242149 |
| 55 | regulation of tolerance induction (GO:0002643) | 3.54711654 |
| 56 | negative regulation of interleukin-12 production (GO:0032695) | 3.53451301 |
| 57 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.52035681 |
| 58 | T cell costimulation (GO:0031295) | 3.51211127 |
| 59 | lymphocyte homeostasis (GO:0002260) | 3.50265376 |
| 60 | neutrophil activation (GO:0042119) | 3.48111227 |
| 61 | lymphocyte costimulation (GO:0031294) | 3.46247426 |
| 62 | detection of external biotic stimulus (GO:0098581) | 3.41929478 |
| 63 | NIK/NF-kappaB signaling (GO:0038061) | 3.40968325 |
| 64 | cellular response to zinc ion (GO:0071294) | 3.38730925 |
| 65 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.38381205 |
| 66 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.36069098 |
| 67 | regulation of regulatory T cell differentiation (GO:0045589) | 3.35226337 |
| 68 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.31803572 |
| 69 | hepatocyte apoptotic process (GO:0097284) | 3.31726374 |
| 70 | megakaryocyte development (GO:0035855) | 3.30241855 |
| 71 | myeloid cell activation involved in immune response (GO:0002275) | 3.29753016 |
| 72 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.29726969 |
| 73 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.28579994 |
| 74 | mature B cell differentiation (GO:0002335) | 3.28574400 |
| 75 | regulation of T cell tolerance induction (GO:0002664) | 3.26885101 |
| 76 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.26449384 |
| 77 | immunoglobulin mediated immune response (GO:0016064) | 3.24674861 |
| 78 | leukocyte homeostasis (GO:0001776) | 3.23395230 |
| 79 | response to type I interferon (GO:0034340) | 3.22663972 |
| 80 | tolerance induction (GO:0002507) | 3.21307980 |
| 81 | response to peptidoglycan (GO:0032494) | 3.21011085 |
| 82 | positive regulation of granulocyte differentiation (GO:0030854) | 3.20875910 |
| 83 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.19973723 |
| 84 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.19735110 |
| 85 | response to host immune response (GO:0052572) | 3.19735110 |
| 86 | lymph node development (GO:0048535) | 3.19447490 |
| 87 | B cell mediated immunity (GO:0019724) | 3.17342349 |
| 88 | granulocyte activation (GO:0036230) | 3.16843939 |
| 89 | cellular response to type I interferon (GO:0071357) | 3.16176995 |
| 90 | type I interferon signaling pathway (GO:0060337) | 3.16176995 |
| 91 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.15998299 |
| 92 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.14814916 |
| 93 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.13439572 |
| 94 | myeloid dendritic cell activation (GO:0001773) | 3.12083582 |
| 95 | response to muramyl dipeptide (GO:0032495) | 3.10993665 |
| 96 | defense response to protozoan (GO:0042832) | 3.07432575 |
| 97 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.07115050 |
| 98 | germinal center formation (GO:0002467) | 3.06274452 |
| 99 | negative regulation of innate immune response (GO:0045824) | 3.06149971 |
| 100 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.05176391 |
| 101 | positive regulation of interleukin-2 production (GO:0032743) | 3.04383749 |
| 102 | response to protozoan (GO:0001562) | 3.02687532 |
| 103 | microglial cell activation (GO:0001774) | 3.01559900 |
| 104 | respiratory burst (GO:0045730) | 3.01325547 |
| 105 | regulation of antigen processing and presentation (GO:0002577) | 3.01309190 |
| 106 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.01184645 |
| 107 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.01046249 |
| 108 | regulation of cell killing (GO:0031341) | 3.00471604 |
| 109 | detection of biotic stimulus (GO:0009595) | 2.97508501 |
| 110 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.96545964 |
| 111 | response to host (GO:0075136) | 2.96545964 |
| 112 | response to host defenses (GO:0052200) | 2.96545964 |
| 113 | mature B cell differentiation involved in immune response (GO:0002313) | 2.95739297 |
| 114 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.95666526 |
| 115 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.95666526 |
| 116 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.95065018 |
| 117 | regulation of mast cell degranulation (GO:0043304) | 2.95029904 |
| 118 | V(D)J recombination (GO:0033151) | 2.92749005 |
| 119 | natural killer cell activation (GO:0030101) | 2.92723136 |
| 120 | T cell proliferation (GO:0042098) | 2.91492776 |
| 121 | leukocyte cell-cell adhesion (GO:0007159) | 2.91038524 |
| 122 | T cell differentiation (GO:0030217) | 2.89597978 |
| 123 | regulation of response to interferon-gamma (GO:0060330) | 2.89118782 |
| 124 | B cell homeostasis (GO:0001782) | 2.88696067 |
| 125 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.88626376 |
| 126 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.88535753 |
| 127 | natural killer cell differentiation (GO:0001779) | 2.88401246 |
| 128 | positive regulation of tolerance induction (GO:0002645) | 2.87496485 |
| 129 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.82966712 |
| 130 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.82966712 |
| 131 | leukocyte degranulation (GO:0043299) | 2.80354849 |
| 132 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.80143231 |
| 133 | activated T cell proliferation (GO:0050798) | 2.78455728 |
| 134 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.78132693 |
| 135 | lymphocyte proliferation (GO:0046651) | 2.77366071 |
| 136 | B cell proliferation (GO:0042100) | 2.77111805 |
| 137 | mononuclear cell proliferation (GO:0032943) | 2.75336812 |
| 138 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.74801918 |
| 139 | positive regulation of lamellipodium assembly (GO:0010592) | 2.74104077 |
| 140 | viral transcription (GO:0019083) | 2.73071193 |
| 141 | Peyers patch development (GO:0048541) | 2.72821133 |
| 142 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.72821133 |
| 143 | regulation of granulocyte differentiation (GO:0030852) | 2.71752089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.42230474 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.82288732 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.69275649 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.13495706 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.06305528 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.73393218 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.56998929 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.42028210 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.35513478 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.08487556 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.08101021 |
| 12 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.98105974 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.89441056 |
| 14 | * MYB_26560356_Chip-Seq_TH2_Human | 2.84709428 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.83261121 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.80762364 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.76270053 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.74001066 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73867326 |
| 20 | * MAF_26560356_Chip-Seq_TH1_Human | 2.61246179 |
| 21 | * MYB_26560356_Chip-Seq_TH1_Human | 2.50965029 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.44125585 |
| 23 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.38960389 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.38830245 |
| 25 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.38812486 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.38145448 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.35329209 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26814997 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25170945 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.14955638 |
| 31 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.14686523 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.14563247 |
| 33 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.09073686 |
| 34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.08048166 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.07029758 |
| 36 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.05201844 |
| 37 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00603025 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96718050 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86990437 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86428612 |
| 41 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81976978 |
| 42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.76480362 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.75259836 |
| 44 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.74162448 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73479189 |
| 46 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.70297049 |
| 47 | * MAF_26560356_Chip-Seq_TH2_Human | 1.65904695 |
| 48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64107392 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63625487 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63567547 |
| 51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.56357919 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53804328 |
| 53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53193463 |
| 54 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.52347594 |
| 55 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.49035140 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48610377 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45567359 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.44762199 |
| 59 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.41678800 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.40798556 |
| 61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38061608 |
| 62 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36439470 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33707434 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33218125 |
| 65 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.32343152 |
| 66 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.31812417 |
| 67 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.30860323 |
| 68 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.28502149 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25141241 |
| 70 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24664765 |
| 71 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.23077485 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22607783 |
| 73 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.22001312 |
| 74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16824801 |
| 75 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.14940695 |
| 76 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14891522 |
| 77 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.14375040 |
| 78 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.14019318 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09934809 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08886141 |
| 81 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07143362 |
| 82 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.06764841 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03822586 |
| 84 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02564378 |
| 85 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.02285825 |
| 86 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01538839 |
| 87 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00903129 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00336811 |
| 89 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00001390 |
| 90 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99861734 |
| 91 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.98531970 |
| 92 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97277321 |
| 93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96388347 |
| 94 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.95860601 |
| 95 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91071398 |
| 96 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89298147 |
| 97 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88996574 |
| 98 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.88673407 |
| 99 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84248281 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84245879 |
| 101 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.83938245 |
| 102 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.82892927 |
| 103 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82554200 |
| 104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81626133 |
| 105 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81213513 |
| 106 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81026832 |
| 107 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80171257 |
| 108 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79797064 |
| 109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79433139 |
| 110 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.78199392 |
| 111 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.77488026 |
| 112 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.75806340 |
| 113 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.74684100 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74627738 |
| 115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73263944 |
| 116 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.71842097 |
| 117 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.70438984 |
| 118 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69629946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.34732600 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.98090834 |
| 3 | MP0005671_abnormal_response_to | 3.89980256 |
| 4 | MP0000685_abnormal_immune_system | 3.60889922 |
| 5 | MP0001800_abnormal_humoral_immune | 3.52486416 |
| 6 | MP0002396_abnormal_hematopoietic_system | 3.52441761 |
| 7 | MP0001790_abnormal_immune_system | 3.08237657 |
| 8 | MP0005387_immune_system_phenotype | 3.08237657 |
| 9 | MP0002452_abnormal_antigen_presenting | 2.92271135 |
| 10 | MP0009785_altered_susceptibility_to | 2.91414713 |
| 11 | MP0002398_abnormal_bone_marrow | 2.90391360 |
| 12 | * MP0002420_abnormal_adaptive_immunity | 2.89929249 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.86231680 |
| 14 | * MP0001819_abnormal_immune_cell | 2.85257068 |
| 15 | MP0002723_abnormal_immune_serum | 2.83612317 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.83570029 |
| 17 | MP0005025_abnormal_response_to | 2.63642338 |
| 18 | MP0003436_decreased_susceptibility_to | 2.58682405 |
| 19 | MP0000716_abnormal_immune_system | 2.55040346 |
| 20 | MP0000689_abnormal_spleen_morphology | 2.42175161 |
| 21 | MP0002722_abnormal_immune_system | 2.33799751 |
| 22 | MP0000703_abnormal_thymus_morphology | 2.30204497 |
| 23 | MP0002419_abnormal_innate_immunity | 2.26185794 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.25791840 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 2.24800643 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.21545697 |
| 27 | MP0002006_tumorigenesis | 2.16976154 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 2.15444744 |
| 29 | MP0002429_abnormal_blood_cell | 2.14287300 |
| 30 | MP0003303_peritoneal_inflammation | 2.13747168 |
| 31 | MP0002405_respiratory_system_inflammati | 2.10462319 |
| 32 | MP0001873_stomach_inflammation | 2.00449172 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.99245626 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.85331523 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.85331523 |
| 36 | MP0003724_increased_susceptibility_to | 1.84627850 |
| 37 | MP0003866_abnormal_defecation | 1.82231653 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.76291397 |
| 39 | MP0005174_abnormal_tail_pigmentation | 1.70101617 |
| 40 | MP0006082_CNS_inflammation | 1.68993604 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.68721586 |
| 42 | MP0002933_joint_inflammation | 1.63918242 |
| 43 | MP0001853_heart_inflammation | 1.62666017 |
| 44 | MP0004947_skin_inflammation | 1.62531696 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.60725463 |
| 46 | MP0005075_abnormal_melanosome_morpholog | 1.58469109 |
| 47 | MP0009278_abnormal_bone_marrow | 1.55201073 |
| 48 | MP0008260_abnormal_autophagy | 1.50011236 |
| 49 | MP0000490_abnormal_crypts_of | 1.38116246 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.33549699 |
| 51 | MP0004510_myositis | 1.26710349 |
| 52 | MP0002095_abnormal_skin_pigmentation | 1.16277161 |
| 53 | MP0005451_abnormal_body_composition | 1.15395785 |
| 54 | MP0010094_abnormal_chromosome_stability | 1.15392774 |
| 55 | MP0000858_altered_metastatic_potential | 1.13660504 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.13390568 |
| 57 | MP0008469_abnormal_protein_level | 1.13018915 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.11820488 |
| 59 | MP0008057_abnormal_DNA_replication | 1.10407623 |
| 60 | MP0008007_abnormal_cellular_replicative | 1.03986477 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.02183775 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.01136606 |
| 63 | MP0005310_abnormal_salivary_gland | 0.99567376 |
| 64 | MP0001986_abnormal_taste_sensitivity | 0.98560088 |
| 65 | MP0004883_abnormal_blood_vessel | 0.96524886 |
| 66 | MP0003077_abnormal_cell_cycle | 0.96005345 |
| 67 | MP0001851_eye_inflammation | 0.90642160 |
| 68 | MP0000015_abnormal_ear_pigmentation | 0.87936626 |
| 69 | MP0006054_spinal_hemorrhage | 0.86074327 |
| 70 | MP0005166_decreased_susceptibility_to | 0.84991500 |
| 71 | MP0002132_abnormal_respiratory_system | 0.83404521 |
| 72 | MP0008058_abnormal_DNA_repair | 0.80527693 |
| 73 | MP0003075_altered_response_to | 0.79613042 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 0.76256482 |
| 75 | MP0003045_fibrosis | 0.74188320 |
| 76 | MP0003448_altered_tumor_morphology | 0.73984639 |
| 77 | MP0009763_increased_sensitivity_to | 0.73710917 |
| 78 | MP0003690_abnormal_glial_cell | 0.73402150 |
| 79 | MP0010352_gastrointestinal_tract_polyps | 0.72903914 |
| 80 | MP0000604_amyloidosis | 0.71122602 |
| 81 | MP0003693_abnormal_embryo_hatching | 0.70510123 |
| 82 | MP0003111_abnormal_nucleus_morphology | 0.70109777 |
| 83 | MP0004381_abnormal_hair_follicle | 0.69633693 |
| 84 | MP0005058_abnormal_lysosome_morphology | 0.69034498 |
| 85 | MP0004147_increased_porphyrin_level | 0.68997271 |
| 86 | MP0003172_abnormal_lysosome_physiology | 0.68609566 |
| 87 | MP0005390_skeleton_phenotype | 0.67948740 |
| 88 | MP0003943_abnormal_hepatobiliary_system | 0.67812877 |
| 89 | MP0009764_decreased_sensitivity_to | 0.67651238 |
| 90 | MP0002998_abnormal_bone_remodeling | 0.65404177 |
| 91 | MP0005164_abnormal_response_to | 0.65253244 |
| 92 | MP0003828_pulmonary_edema | 0.64288971 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.64162727 |
| 94 | MP0001663_abnormal_digestive_system | 0.63792559 |
| 95 | MP0000343_altered_response_to | 0.61410101 |
| 96 | MP0002009_preneoplasia | 0.60410330 |
| 97 | MP0000313_abnormal_cell_death | 0.59622962 |
| 98 | MP0004130_abnormal_muscle_cell | 0.57920624 |
| 99 | MP0005409_darkened_coat_color | 0.57500823 |
| 100 | MP0008874_decreased_physiological_sensi | 0.56912189 |
| 101 | MP0000477_abnormal_intestine_morphology | 0.56763482 |
| 102 | MP0005023_abnormal_wound_healing | 0.55472120 |
| 103 | MP0008004_abnormal_stomach_pH | 0.54928973 |
| 104 | MP0008569_lethality_at_weaning | 0.54055990 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.54027503 |
| 106 | MP0002693_abnormal_pancreas_physiology | 0.53171788 |
| 107 | MP0001348_abnormal_lacrimal_gland | 0.51929876 |
| 108 | MP0010307_abnormal_tumor_latency | 0.51734348 |
| 109 | MP0003795_abnormal_bone_structure | 0.50599094 |
| 110 | MP0003252_abnormal_bile_duct | 0.49602518 |
| 111 | MP0008961_abnormal_basal_metabolism | 0.48420292 |
| 112 | MP0003279_aneurysm | 0.48007818 |
| 113 | MP0000249_abnormal_blood_vessel | 0.47709061 |
| 114 | MP0002928_abnormal_bile_duct | 0.46682781 |
| 115 | MP0002083_premature_death | 0.45613121 |
| 116 | MP0008873_increased_physiological_sensi | 0.44818053 |
| 117 | MP0005381_digestive/alimentary_phenotyp | 0.44467339 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.44273627 |
| 119 | MP0000609_abnormal_liver_physiology | 0.43353845 |
| 120 | MP0001765_abnormal_ion_homeostasis | 0.39230031 |
| 121 | MP0003091_abnormal_cell_migration | 0.39094163 |
| 122 | MP0002133_abnormal_respiratory_system | 0.38726666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 5.43359131 |
| 2 | Recurrent bronchitis (HP:0002837) | 5.16996415 |
| 3 | IgM deficiency (HP:0002850) | 4.94309802 |
| 4 | Panhypogammaglobulinemia (HP:0003139) | 4.91873355 |
| 5 | Chronic otitis media (HP:0000389) | 4.84014539 |
| 6 | T lymphocytopenia (HP:0005403) | 4.81456518 |
| 7 | Recurrent viral infections (HP:0004429) | 4.71703312 |
| 8 | Abnormality of T cell number (HP:0011839) | 4.62851236 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.45592943 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.38908267 |
| 11 | B lymphocytopenia (HP:0010976) | 4.32345036 |
| 12 | Abnormality of B cell number (HP:0010975) | 4.32345036 |
| 13 | Thyroiditis (HP:0100646) | 4.30050190 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.22975890 |
| 15 | Meningitis (HP:0001287) | 4.09584231 |
| 16 | Abnormality of T cells (HP:0002843) | 4.08867400 |
| 17 | Recurrent abscess formation (HP:0002722) | 4.02965038 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 3.93975972 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.93805534 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.93805534 |
| 21 | Cellulitis (HP:0100658) | 3.90216904 |
| 22 | Thrombocytosis (HP:0001894) | 3.81303494 |
| 23 | Lymphopenia (HP:0001888) | 3.80714304 |
| 24 | Severe combined immunodeficiency (HP:0004430) | 3.75926405 |
| 25 | Gastrointestinal stroma tumor (HP:0100723) | 3.73828611 |
| 26 | IgG deficiency (HP:0004315) | 3.72945471 |
| 27 | Inflammation of the large intestine (HP:0002037) | 3.69181951 |
| 28 | Gastrointestinal inflammation (HP:0004386) | 3.68945837 |
| 29 | Myositis (HP:0100614) | 3.68249854 |
| 30 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.65758343 |
| 31 | Colitis (HP:0002583) | 3.61132096 |
| 32 | Eczematoid dermatitis (HP:0000976) | 3.52431930 |
| 33 | Nasal polyposis (HP:0100582) | 3.51745967 |
| 34 | Combined immunodeficiency (HP:0005387) | 3.47019251 |
| 35 | Recurrent sinusitis (HP:0011108) | 3.45362261 |
| 36 | Increased IgM level (HP:0003496) | 3.45186499 |
| 37 | Papilloma (HP:0012740) | 3.44614427 |
| 38 | Verrucae (HP:0200043) | 3.44614427 |
| 39 | Abnormality of the fingertips (HP:0001211) | 3.35682697 |
| 40 | Recurrent bacterial skin infections (HP:0005406) | 3.34837960 |
| 41 | Abnormality of T cell physiology (HP:0011840) | 3.31023133 |
| 42 | Chronic sinusitis (HP:0011109) | 3.23808074 |
| 43 | Chronic diarrhea (HP:0002028) | 3.21771020 |
| 44 | Abnormality of eosinophils (HP:0001879) | 3.12695096 |
| 45 | Spontaneous hematomas (HP:0007420) | 3.10821187 |
| 46 | Keratoconjunctivitis (HP:0001096) | 3.10818504 |
| 47 | Abnormality of the nasal mucosa (HP:0000433) | 3.09779058 |
| 48 | Hypoplasia of the thymus (HP:0000778) | 3.09320803 |
| 49 | Vasculitis (HP:0002633) | 3.08794705 |
| 50 | Recurrent skin infections (HP:0001581) | 3.07626538 |
| 51 | Urticaria (HP:0001025) | 3.06282454 |
| 52 | Eosinophilia (HP:0001880) | 3.04822170 |
| 53 | Gingivitis (HP:0000230) | 2.94496609 |
| 54 | Mediastinal lymphadenopathy (HP:0100721) | 2.92623167 |
| 55 | Bronchitis (HP:0012387) | 2.88362224 |
| 56 | Stomatitis (HP:0010280) | 2.83935245 |
| 57 | Granulocytopenia (HP:0001913) | 2.81138153 |
| 58 | Prolonged bleeding time (HP:0003010) | 2.76742127 |
| 59 | Hypochromic anemia (HP:0001931) | 2.75791360 |
| 60 | Obstructive lung disease (HP:0006536) | 2.73203943 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.73203943 |
| 62 | Lymphoma (HP:0002665) | 2.72292335 |
| 63 | Encephalitis (HP:0002383) | 2.69707316 |
| 64 | Leukocytosis (HP:0001974) | 2.68085496 |
| 65 | Pulmonary embolism (HP:0002204) | 2.65922025 |
| 66 | Gingival bleeding (HP:0000225) | 2.64795672 |
| 67 | IgA deficiency (HP:0002720) | 2.62867303 |
| 68 | Abnormality of the prostate (HP:0008775) | 2.60858303 |
| 69 | Emphysema (HP:0002097) | 2.56877472 |
| 70 | Pustule (HP:0200039) | 2.55111254 |
| 71 | Autoimmune hemolytic anemia (HP:0001890) | 2.51589146 |
| 72 | Hypochromic microcytic anemia (HP:0004840) | 2.50723908 |
| 73 | Osteomyelitis (HP:0002754) | 2.49892104 |
| 74 | Petechiae (HP:0000967) | 2.48783960 |
| 75 | Autoimmune thrombocytopenia (HP:0001973) | 2.45738677 |
| 76 | Papilledema (HP:0001085) | 2.45407258 |
| 77 | Epistaxis (HP:0000421) | 2.36648162 |
| 78 | Sepsis (HP:0100806) | 2.36396968 |
| 79 | Abnormality of the pleura (HP:0002103) | 2.34717004 |
| 80 | Basal cell carcinoma (HP:0002671) | 2.34249829 |
| 81 | Anorexia (HP:0002039) | 2.33891794 |
| 82 | Recurrent pneumonia (HP:0006532) | 2.32527052 |
| 83 | Recurrent lower respiratory tract infections (HP:0002783) | 2.29743565 |
| 84 | Gangrene (HP:0100758) | 2.29143953 |
| 85 | Joint swelling (HP:0001386) | 2.27591869 |
| 86 | Hemoptysis (HP:0002105) | 2.27235046 |
| 87 | Episodic fever (HP:0001954) | 2.25505029 |
| 88 | Skin rash (HP:0000988) | 2.21567932 |
| 89 | Acute hepatic failure (HP:0006554) | 2.20723492 |
| 90 | Recurrent otitis media (HP:0000403) | 2.19407353 |
| 91 | Increased IgE level (HP:0003212) | 2.16725164 |
| 92 | Optic neuritis (HP:0100653) | 2.15742240 |
| 93 | Retrobulbar optic neuritis (HP:0100654) | 2.15742240 |
| 94 | Microcytic anemia (HP:0001935) | 2.12395260 |
| 95 | Arterial thrombosis (HP:0004420) | 2.12336220 |
| 96 | Periodontitis (HP:0000704) | 2.10552673 |
| 97 | Amaurosis fugax (HP:0100576) | 2.08905134 |
| 98 | Chest pain (HP:0100749) | 2.08413956 |
| 99 | Glomerulopathy (HP:0100820) | 2.07538329 |
| 100 | Orchitis (HP:0100796) | 2.06645316 |
| 101 | Stomach cancer (HP:0012126) | 2.05972217 |
| 102 | Cheilitis (HP:0100825) | 2.04711099 |
| 103 | Restrictive lung disease (HP:0002091) | 2.04389313 |
| 104 | Skin ulcer (HP:0200042) | 2.01117302 |
| 105 | Neutropenia (HP:0001875) | 2.00831436 |
| 106 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.00441906 |
| 107 | Pulmonary infiltrates (HP:0002113) | 2.00433515 |
| 108 | Viral hepatitis (HP:0006562) | 1.99386105 |
| 109 | Acute lymphatic leukemia (HP:0006721) | 1.98448654 |
| 110 | Purpura (HP:0000979) | 1.97355140 |
| 111 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.96861839 |
| 112 | Slow saccadic eye movements (HP:0000514) | 1.96647189 |
| 113 | Hypoproteinemia (HP:0003075) | 1.95740555 |
| 114 | Reticulocytopenia (HP:0001896) | 1.95499959 |
| 115 | Hypergammaglobulinemia (HP:0010702) | 1.93857202 |
| 116 | Leukopenia (HP:0001882) | 1.93304743 |
| 117 | Acute myeloid leukemia (HP:0004808) | 1.93031849 |
| 118 | Arthralgia (HP:0002829) | 1.92508538 |
| 119 | Interstitial pulmonary disease (HP:0006530) | 1.91015728 |
| 120 | Abnormality of macrophages (HP:0004311) | 1.89987064 |
| 121 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.89211395 |
| 122 | Keratoconjunctivitis sicca (HP:0001097) | 1.85076882 |
| 123 | Poikiloderma (HP:0001029) | 1.84940187 |
| 124 | Hematochezia (HP:0002573) | 1.82618092 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.20928729 |
| 2 | TXK | 3.36109901 |
| 3 | KIT | 2.90169038 |
| 4 | MAP3K10 | 2.56346986 |
| 5 | PRPF4B | 2.46589760 |
| 6 | BTK | 2.40854914 |
| 7 | EEF2K | 2.38526063 |
| 8 | ZAP70 | 2.34660923 |
| 9 | GRK6 | 2.31758830 |
| 10 | TYK2 | 2.29967044 |
| 11 | TEC | 2.29162967 |
| 12 | ITK | 2.27486452 |
| 13 | JAK3 | 2.19599047 |
| 14 | CSF1R | 2.19289365 |
| 15 | BLK | 2.11543973 |
| 16 | STK10 | 2.10852346 |
| 17 | FLT3 | 2.08048408 |
| 18 | IKBKE | 2.06767185 |
| 19 | SYK | 2.01902657 |
| 20 | MAP3K14 | 1.88790880 |
| 21 | IRAK4 | 1.68548265 |
| 22 | LCK | 1.66662302 |
| 23 | FGFR3 | 1.66468620 |
| 24 | TBK1 | 1.64147510 |
| 25 | FES | 1.62517008 |
| 26 | PIK3CG | 1.58569067 |
| 27 | CLK1 | 1.58449109 |
| 28 | NLK | 1.57722822 |
| 29 | JAK1 | 1.54893805 |
| 30 | HCK | 1.51071980 |
| 31 | RIPK4 | 1.47364797 |
| 32 | TGFBR2 | 1.47241257 |
| 33 | MAP3K13 | 1.43986752 |
| 34 | FGFR4 | 1.43784069 |
| 35 | SIK2 | 1.41853139 |
| 36 | CSK | 1.32642155 |
| 37 | MAP3K11 | 1.32205631 |
| 38 | MAP2K3 | 1.29180778 |
| 39 | LYN | 1.27367154 |
| 40 | SIK3 | 1.25802173 |
| 41 | ERN1 | 1.14778379 |
| 42 | IKBKB | 1.13964511 |
| 43 | FGR | 1.10957825 |
| 44 | MARK3 | 1.10379502 |
| 45 | LRRK2 | 1.09423421 |
| 46 | NME2 | 1.07416609 |
| 47 | MAP3K3 | 1.07311943 |
| 48 | PKN2 | 1.05913036 |
| 49 | PIM1 | 1.05135615 |
| 50 | BMPR2 | 1.04188664 |
| 51 | TAOK1 | 1.01486896 |
| 52 | KDR | 0.95860920 |
| 53 | CAMKK1 | 0.91337227 |
| 54 | TNK2 | 0.89272191 |
| 55 | MAP3K1 | 0.89140028 |
| 56 | CAMKK2 | 0.83039949 |
| 57 | RPS6KA4 | 0.81545023 |
| 58 | PRKCH | 0.80645896 |
| 59 | TNIK | 0.80017685 |
| 60 | MATK | 0.73105721 |
| 61 | TGFBR1 | 0.71993193 |
| 62 | PRKCQ | 0.70248385 |
| 63 | RPS6KB2 | 0.69906722 |
| 64 | MAPK11 | 0.69760247 |
| 65 | YES1 | 0.69174235 |
| 66 | TAOK3 | 0.69104272 |
| 67 | STK4 | 0.66983007 |
| 68 | KSR2 | 0.65534898 |
| 69 | CDK4 | 0.64248763 |
| 70 | MAP3K7 | 0.63001535 |
| 71 | EPHB1 | 0.61869166 |
| 72 | JAK2 | 0.59853758 |
| 73 | MAP3K12 | 0.59375067 |
| 74 | NEK2 | 0.58809371 |
| 75 | PDK1 | 0.58141119 |
| 76 | MAPK4 | 0.57047990 |
| 77 | MST4 | 0.56371108 |
| 78 | CDC42BPA | 0.56207590 |
| 79 | SMG1 | 0.54434598 |
| 80 | CHUK | 0.54139995 |
| 81 | PDPK1 | 0.53087957 |
| 82 | MAP2K2 | 0.52861014 |
| 83 | ADRBK2 | 0.52693283 |
| 84 | IRAK3 | 0.52418844 |
| 85 | MAPK12 | 0.52137404 |
| 86 | HIPK2 | 0.51906337 |
| 87 | IRAK1 | 0.50377178 |
| 88 | EIF2AK3 | 0.49721232 |
| 89 | TAOK2 | 0.49636534 |
| 90 | TESK2 | 0.48065765 |
| 91 | PTK6 | 0.47433692 |
| 92 | TRPM7 | 0.46713377 |
| 93 | MAPK7 | 0.45363227 |
| 94 | PRKD2 | 0.44549821 |
| 95 | PTK2B | 0.42849419 |
| 96 | ATR | 0.41367509 |
| 97 | EPHA3 | 0.41362509 |
| 98 | TLK1 | 0.41234038 |
| 99 | MARK2 | 0.40740589 |
| 100 | PASK | 0.40179095 |
| 101 | FGFR2 | 0.39307441 |
| 102 | RPS6KA6 | 0.38812288 |
| 103 | MAPKAPK3 | 0.38401953 |
| 104 | SGK3 | 0.37540808 |
| 105 | FYN | 0.36715685 |
| 106 | STK24 | 0.36650309 |
| 107 | MAP3K5 | 0.35857999 |
| 108 | FRK | 0.34938564 |
| 109 | BRD4 | 0.34644592 |
| 110 | RET | 0.34202537 |
| 111 | STK11 | 0.34145864 |
| 112 | ACVR1B | 0.33400396 |
| 113 | CDK12 | 0.33325293 |
| 114 | CDK19 | 0.33018575 |
| 115 | VRK1 | 0.32236668 |
| 116 | SIK1 | 0.32090912 |
| 117 | TRIB3 | 0.31365682 |
| 118 | DYRK1B | 0.31102538 |
| 119 | CDK9 | 0.29358293 |
| 120 | SGK2 | 0.29238033 |
| 121 | RPS6KC1 | 0.28424081 |
| 122 | RPS6KL1 | 0.28424081 |
| 123 | ALK | 0.28180935 |
| 124 | MAP2K6 | 0.28044678 |
| 125 | ABL1 | 0.27143613 |
| 126 | CDK6 | 0.27122698 |
| 127 | MAPKAPK2 | 0.26649865 |
| 128 | GRK7 | 0.25086869 |
| 129 | RAF1 | 0.23862365 |
| 130 | PRKCD | 0.22316550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.50508305 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.14015673 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.52905136 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.49936689 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.42331488 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.39048745 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.37753186 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.35645241 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.35200806 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.17549233 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14162230 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.12206013 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12096751 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.83123657 |
| 15 | DNA replication_Homo sapiens_hsa03030 | 1.74331947 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.67461902 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.65875910 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64739252 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.59397934 |
| 20 | Ribosome_Homo sapiens_hsa03010 | 1.59393088 |
| 21 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.56696146 |
| 22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.56616285 |
| 23 | Mismatch repair_Homo sapiens_hsa03430 | 1.53503419 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.51601461 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.42851551 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42267362 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39461921 |
| 28 | Platelet activation_Homo sapiens_hsa04611 | 1.34137373 |
| 29 | Base excision repair_Homo sapiens_hsa03410 | 1.33584561 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32030045 |
| 31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.31607282 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.31377725 |
| 33 | Allograft rejection_Homo sapiens_hsa05330 | 1.28732264 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.24594914 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22545296 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.17411674 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.11942477 |
| 38 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.09796118 |
| 39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06044032 |
| 40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04774580 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04667947 |
| 42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.04387096 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.01386200 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.00767677 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 0.96604001 |
| 46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95926298 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93528770 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 0.93409073 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 0.92500437 |
| 50 | Homologous recombination_Homo sapiens_hsa03440 | 0.91391781 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91118199 |
| 52 | Spliceosome_Homo sapiens_hsa03040 | 0.90100613 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88923695 |
| 54 | HTLV-I infection_Homo sapiens_hsa05166 | 0.88757967 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.87749264 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87332857 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.87050408 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84819733 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84546124 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83592798 |
| 61 | Colorectal cancer_Homo sapiens_hsa05210 | 0.81893066 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.81249826 |
| 63 | Malaria_Homo sapiens_hsa05144 | 0.77527181 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77425328 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75185373 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.72726589 |
| 67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72039738 |
| 68 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.68335698 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67332214 |
| 70 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66694081 |
| 71 | RNA degradation_Homo sapiens_hsa03018 | 0.65593761 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63447079 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63223177 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 0.61306170 |
| 75 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.61161503 |
| 76 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61020850 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.60306504 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60058755 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59006439 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55907842 |
| 81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54458410 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.54101853 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52992690 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52440666 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52151811 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51597072 |
| 87 | Asthma_Homo sapiens_hsa05310 | 0.50071054 |
| 88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48959283 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48885372 |
| 90 | Cell cycle_Homo sapiens_hsa04110 | 0.48672303 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48043443 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43625444 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43190644 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42712455 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41799254 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40821667 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39854402 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39574127 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38256352 |
| 100 | Lysosome_Homo sapiens_hsa04142 | 0.37163670 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36461190 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36316343 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35534335 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.34536575 |
| 105 | Long-term potentiation_Homo sapiens_hsa04720 | 0.33235218 |
| 106 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.32979996 |
| 107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32817732 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31702374 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30780420 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30509480 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29987968 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.29948924 |
| 113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.28367536 |
| 114 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.28331212 |
| 115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28062093 |
| 116 | Prostate cancer_Homo sapiens_hsa05215 | 0.27507665 |
| 117 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27429706 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27084365 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.26666530 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.24779449 |
| 121 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.22384235 |
| 122 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20714949 |

